REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $281,000 | +8.1% | 1,800 | 0.0% | 0.00% | -25.0% |
Q1 2020 | $260,000 | -29.3% | 1,800 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $368,000 | +0.8% | 1,800 | -72.4% | 0.00% | 0.0% |
Q4 2018 | $365,000 | -6.4% | 6,510 | +36.6% | 0.00% | 0.0% |
Q3 2018 | $390,000 | – | 4,765 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $76,391,000 | 14.09% |
Opaleye Management Inc. | 330,000 | $8,702,000 | 1.85% |
Highlander Partners, L.P. | 27,600 | $728,000 | 0.89% |
Ikarian Capital, LLC | 200,000 | $5,274,000 | 0.79% |
Integral Health Asset Management, LLC | 103,000 | $2,716,000 | 0.75% |
KRS Capital Management, LLC | 32,841 | $866,000 | 0.74% |
Ghost Tree Capital, LLC | 55,000 | $1,450,000 | 0.52% |
MADDEN SECURITIES Corp | 39,312 | $1,037,000 | 0.49% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $801,000 | 0.47% |
Ikarian Capital, LLC | 100,000 | $2,637,000 | 0.39% |